XELOX (capecitabine + oxaliplatin)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for XELOX (capecitabine + oxaliplatin), covering 2024-07-17 to 2024-07-17. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II Trial of Perioperative Adebrelimab Combined With XELOX in Resectable Locally Advanced Gastric/Gastroesophageal Junction Cancer (GC/GEJC) [Phase 2]